Comparison of cytotoxic markers expression on the surface of lymphocytes in BAL fluid and peripheral blood samples from patients with pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 322s Year: 2004
Correlation between T-cell activation markers on lymphocytes from peripheral blood and bronchoalveolar lavage fluid in sarcoidosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 226s Year: 2003
Comparative analysis of surface antigen expression and DNA content in circulating, tissue and bronchoalveolar lavage lymphocytes in patients with COPD after radiation exposure Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002
Upregulation of expression of membrane apoptosis signals by bronchoalveolar lavage cells in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
aE b7 integrin (CD103-b7 ) expression in bronchoalveolar T lymphocytes in interstitial lung diseasesSource: Eur Respir J 2007; 30: Suppl. 51, 576s Year: 2007
Circulating inflammatory proteins and red blood cells antioxidant activity in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 537s Year: 2003
BALF cell differential, lymphocyte subsets and lung function correlation in connective tissue or collagen vascular disease with pulmonary involvement Source: Eur Respir J 2006; 28: Suppl. 50, 541s Year: 2006
Diminished peripheral T cell activity in sarcoidosis associates with progressive disease. Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype Year: 2018
Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005
Rapid decline in lung function in COPD is associated with decreased CD25brightFoxP3 regulatory T cells in BAL Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
Reduced expression of PPAR-alpha in bronchoalveolar lavage CD4+ T cells of sarcoidosis patients Source: Annual Congress 2011 - T-cell subsets Year: 2011
BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Analysis of Immunoglobulin A and M gene expression and plasma cells in bronchial tissue from COPD patients with high blood eosinophil counts Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases Year: 2018
Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling. Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018
Different profiles of lung and systemic regulatory T cells in mild asthmatics Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010
Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients Source: Eur Respir J 2003; 21: 52-57 Year: 2003
Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017
BAL protein profiles specific of different interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Features of cytokine production, subpopulation structure of lymphocytes and functional state of neutrophils in patients with disseminated MDR tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 588s Year: 2006
Decreased numbers of human peripheral blood CD8+ve T-lymphocytes and the modification of their specific surface antigens in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002